$12.38
Price
$10.3B
Market Cap
29.5
P/E Ratio
19.0
Forward P/E
$0.42
EPS (TTM)
0.67%
Dividend Yield
$81.4B
Cash
$77.3B
Total Debt
833M
Shares Out
$11.36
$15.67
52-Week Range
Institutional Ownership of Dr. Reddy's Laboratories-adr
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Dr. Reddy's Laboratories-adr
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q4 | |||||
| SELL | EXIT | — | — | $14.05 | |
| 2025-Q2 | |||||
| BUY | +10.2% | 159.1K | $2M | $14.14 | |
| 2025-Q1 | |||||
| SELL | -73.2% | 144.4K | $2M | $13.60 | |
| 2024-Q4 | |||||
| BUY | +400.0% | 539.3K | $9M | $15.00 | |
| 2024-Q3 | |||||
| BUY | +1.6% | 107.9K | $9M | $80.37 | |
| 2024-Q2 | |||||
| SELL | -7.9% | 106.2K | $8M | $71.50 | |
| 2023-Q3 | |||||
| SELL | -23.2% | 115.2K | $8M | $68.20 | |
| 2023-Q2 | |||||
| SELL | -6.8% | 150.0K | $9M | $58.97 | |
| 2023-Q1 | |||||
| BUY | +59.6% | 161.0K | $9M | $53.83 | |
| 2022-Q4 | |||||
| BUY | +17.3% | 100.8K | $5M | $54.04 | |
| 2022-Q3 | |||||
| BUY | +81.9% | 86.0K | $4M | $52.90 | |
| 2022-Q2 | |||||
| SELL | -32.3% | 47.3K | $3M | $55.07 | |
| 2022-Q1 | |||||
| SELL | -0.8% | 69.8K | $4M | $56.52 | |
| 2021-Q4 | |||||
| SELL | -13.6% | 70.3K | $5M | $62.99 | |
| 2021-Q3 | |||||
| SELL | -50.1% | 81.3K | $5M | $65.18 | |
| 2021-Q2 | |||||
| BUY | +0.8% | 163.1K | $12M | $71.59 | |
| 2021-Q1 | |||||
| SELL | -16.7% | 161.8K | $10M | $62.20 | |
| 2020-Q4 | |||||
| SELL | -1.7% | 194.3K | $14M | $67.77 | |
| 2020-Q3 | |||||
| BUY | +34.6% | 197.7K | $14M | $59.82 | |
| 2020-Q2 | |||||
| SELL | -6.7% | 146.9K | $8M | $51.42 | |
| 2020-Q1 | |||||
| BUY | +234.5% | 157.3K | $6M | $42.00 | |
| 2019-Q3 | |||||
| BUY | +12.0% | 47.0K | $2M | $37.70 | |
| 2019-Q2 | |||||
| SELL | -2.8% | 42.0K | $2M | $39.68 | |
| 2018-Q1 | |||||
| SELL | -55.0% | 43.2K | $1M | $34.05 | |
Insider Trading for Dr. Reddy's Laboratories-adr
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.